Effects of cytarabine on activation of human T cells – cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acid
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2050-6511
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effects of cytarabine on activation of human T cells – cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acid ; volume:16 ; number:1 ; day:2 ; month:5 ; year:2015 ; pages:1-16 ; date:12.2015
BMC pharmacology & toxicology ; 16, Heft 1 (2.5.2015), 1-16, 12.2015
- Urheber
-
Ersvaer, Elisabeth
- Beteiligte Personen und Organisationen
-
Brenner, Annette K.
Vetås, Kristin
Reikvam, Håkon
Bruserud, Øystein
SpringerLink (Online service)
- DOI
-
10.1186/s40360-015-0012-2
- URN
-
urn:nbn:de:1111-2016110711559
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ersvaer, Elisabeth
- Brenner, Annette K.
- Vetås, Kristin
- Reikvam, Håkon
- Bruserud, Øystein
- SpringerLink (Online service)
Ähnliche Objekte (12)
The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia
Randomized phase-III study of low-dose cytarabine and etoposide + /− all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia
Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial
Cellular Effects of the Antiepileptic Drug Valproic Acid in Glioblastoma
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
Impact of TP53 mutation status in elderly AML patients when adding all‐trans retinoic acid or valproic acid to decitabine
Hand foot syndrome associated with standard dose cytarabine
Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer
Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia
Five Doubly Unsaturated Metabolites of Valproic Acid in Urine and Plasma of Patients on Valproic Acid Therapy
Valproic acid autoinduction: a case-based review
The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia
Randomized phase-III study of low-dose cytarabine and etoposide + /− all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia
Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial
Cellular Effects of the Antiepileptic Drug Valproic Acid in Glioblastoma
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
Impact of TP53 mutation status in elderly AML patients when adding all‐trans retinoic acid or valproic acid to decitabine
Hand foot syndrome associated with standard dose cytarabine
Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer
Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia
Five Doubly Unsaturated Metabolites of Valproic Acid in Urine and Plasma of Patients on Valproic Acid Therapy
Valproic acid autoinduction: a case-based review
The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia
Randomized phase-III study of low-dose cytarabine and etoposide + /− all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia
Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial
Cellular Effects of the Antiepileptic Drug Valproic Acid in Glioblastoma
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
Impact of TP53 mutation status in elderly AML patients when adding all‐trans retinoic acid or valproic acid to decitabine
Hand foot syndrome associated with standard dose cytarabine
Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer
Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia
Five Doubly Unsaturated Metabolites of Valproic Acid in Urine and Plasma of Patients on Valproic Acid Therapy